Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,903 | 49,351 | 132,865 | 0 | 0 |
| Marketable Securities | 210,883 | 212,798 | 144,198 | 0 | 0 |
| TOTAL | $244,276 | $267,286 | $281,170 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,509 | 1,080 | 1,033 | N/A | N/A |
| Other Non-Current Assets | 141 | 169 | 197 | 0 | 0 |
| TOTAL | $1,650 | $1,249 | $1,230 | $N/A | $N/A |
| Total Assets | $245,926 | $268,535 | $282,400 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,245 | 5,335 | 5,002 | 0 | 0 |
| Accrued Expenses | 6,106 | 5,545 | 5,752 | 0 | 0 |
| TOTAL | $10,481 | $11,051 | $10,920 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23 | 42 | 112 | 0 | 0 |
| TOTAL | $23 | $42 | $112 | $N/A | $N/A |
| Total Liabilities | $10,504 | $11,093 | $11,032 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,424 | 33,424 | 33,417 | N/A | N/A |
| Common Shares | 5 | 5 | 5 | 0 | 0 |
| Retained earnings | -161,385 | -137,505 | -121,919 | 0 | 0 |
| Other shareholders' equity | 53 | 55 | 106 | 0 | 0 |
| TOTAL | $235,422 | $257,442 | $271,368 | $0 | $0 |
| Total Liabilities And Equity | $245,926 | $268,535 | $282,400 | $0 | $0 |